The ROE as of September 2024 (TTM) for Seelos Therapeutics, Inc. (SEEL) is -13.07%

According to Seelos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -13.07%. This represents a change of 221.29% compared to the average of -4.07% of the last 4 quarters.

Seelos Therapeutics, Inc. (SEEL) Historical ROE (quarterly & annually)

How has SEEL ROE performed in the past?

The mean historical ROE of Seelos Therapeutics, Inc. over the last ten years is 71.85%. The current -13.07% ROE has changed -100.02% with respect to the historical average. Over the past ten years (40 quarters), SEEL's ROE was at its highest in in the December 2019 quarter at 146.91%. The ROE was at its lowest in in the March 2019 quarter at -1169.31%.

Seelos Therapeutics, Inc. (SEEL) ROE by Quarter and Year

Discovering the peaks and valleys of Seelos Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Seelos Therapeutics, Inc. (SEEL) Average ROE

How has SEEL ROE performed in the past?

The current ROE of Seelos Therapeutics, Inc. (SEEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Seelos Therapeutics, Inc. (SEEL) ROE vs. Peers

How is SEEL’s ROE compared to its peers?

Seelos Therapeutics, Inc.’s ROE is greater than Atai Life Sciences N.V. (-25.82%), greater than Mind Medicine (MindMed) Inc. (-71.33%), greater than GH Research PLC (-16.39%), greater than Freeline Therapeutics Holdings plc (-110.68%), greater than Cybin Inc. (-42.30%), less than Awakn Life Sciences Corp. (292.48%), greater than Pulmatrix, Inc. (-61.78%), greater than Capricor Therapeutics, Inc. (-220.26%), less than Akari Therapeutics, Plc (1.04%), greater than Diffusion Pharmaceuticals Inc. (-55460.19%), greater than Soleno Therapeutics, Inc. (-43.25%), greater than Eliem Therapeutics, Inc. (-47.03%), less than Opthea Limited (360.05%), greater than Molecular Partners AG (-33.08%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than iTeos Therapeutics, Inc. (-18.19%), greater than TRACON Pharmaceuticals, Inc. (-237.65%), greater than Histogen Inc. (-108.33%), greater than Entera Bio Ltd. (-100.37%), greater than Tempest Therapeutics, Inc. (-201.10%), less than Better Therapeutics, Inc. (223.92%),

Build a custom stock screener for Seelos Therapeutics, Inc. (SEEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seelos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Seelos Therapeutics, Inc. (SEEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Seelos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.